It is important to note that these stimuli overlap significantly with the pathological milieu implicated in the genesis and progression of cardiomyopathy in the dialysis population [7],[8], positioning BNP as a potentially important biomarker of cardiac risk in this group. This evidence concerns the gene NPPB and cardiomyopathy.